February 26, 2014

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

Key Points

Key points are not available for this paper at this time.

Abstract

Key Points Selective myeloma cell killing and enhanced effector function of a novel anti-BCMA antibody conjugated with MMAF via noncleavable linker. Specific multiple myeloma antigen for monoclonal antibody-based immunotherapy.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Yu‐Tzu Tai

Patrick A. Mayes

Chirag Acharya

Journals

Blood

Actions

Institutions

Harvard University

Dana-Farber Cancer Institute

Columbia University Irving Medical Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Novel anti–B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study